KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/11/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization239,602 mln
Float14.91 mln
EPS
162
Stretched
P / E
60.86
Richly valued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2
Caution advised
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.39
Low leverage
Business Description
Founded in 1965 and based in Seoul, South Korea, Hyundai Pharmaceutical produces and sells a wide range of medicines, health food drinks, and medical devices both domestically and abroad. Its product lineup covers a broad spectrum of health needs, from heart and allergy treatments to eye care, hormonal therapies, skin conditions, and digestive health, among many others.
